Page last updated: 2024-08-26

imipenem, anhydrous and Neoplasms

imipenem, anhydrous has been researched along with Neoplasms in 56 studies

Research

Studies (56)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (23.21)	18.7374
1990's	28 (50.00)	18.2507
2000's	9 (16.07)	29.6817
2010's	3 (5.36)	24.3611
2020's	3 (5.36)	2.80

Authors

Authors	Studies
Antczak, C; Bassit, B; de Stanchina, E; Djaballah, H; Frattini, MG; Li, Y; Scheinberg, DA; Shum, D	1
Aitken, SL; Gerges, BZ; Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA	1
Aiesh, BM; Alsayed, RB; Amer, R; Rabayah, R; Sabateen, A; Salameh, H; Taha, AA; Zyoud, SH	1
Cui, K; Gao, Y; Guo, Z; He, XR; Hu, Z; Huang, M; Ju, Y; Li, Y; Liu, H; Liu, K; Ma, G; Ma, S; Qiu, Y; Tao, Y; Wang, C; Wang, DH; Wang, G; Wang, H; Wang, Y; Xian, L; Xie, W; Xu, S; Ye, Y; Yu, K; Zhang, G; Zhang, L; Zhang, M; Zhao, J; Zhou, X; Zhu, B; Zhuo, Z	1
Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J	1
Emiroğlu, M; Köksal, Y; Köse, D	1
Bayram, I; Erbey, F; Tanyeli, A; Yilma, S	1
Arpin, C; Bezian, MC; Dubois, V; Gachie, JP; Gavinet, AM; Maire, JP; Menard, F; Quentin, C; Rogues, AM	1
Cámara, JC; Casado, A; Díaz-Rubio, E; Flores, L; García-Sáenz, JA; Macias, JA; Manrique, I; Martín, M; Pérez-Segura, P; Perezagua, C	1
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE	1
Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM	1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C	1
Anagnostopoulos, A; Fassas, A; Hadjikyrkou, M; Kontodimou, A; Papageorgiou, T; Proya, E	1
Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G	1
Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M	1
Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC	1
Craft, AW; Gray, JW; Kernahan, J; Pearson, AD; Pedler, SJ; Windebank, KP	1
Barros, KV; Bianchi, A; Kusano, E; Melaragno, R; Petrilli, AS; Ribeiro, RC; Silva, AA	1
Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y	1
Freifeld, AG	1
Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE	1
Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E	1
Aparicio, J; Gómez-Codina, J; Herranz, C; Llorca, C; Montalar, J; Munárriz, B; Oltra, A; Pastor, M	1
Drgona, L; Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Oravcova, E; Sevcikova, L; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trup, J	1
Bezáková, I; Drgona, L; Grausová, S; Hel'pianska, L; Ilavská, I; Koren, P; Krcméry, V; Krupová, I; Kukucková, E; Kunová, A; Lacka, J; Oravcová, E; Sevcíková, L; Spánik, S; Stopková, K; Studená, M; Svec, J; Trupl, J	1
Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P	1
Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B	1
Abi-Said, D; Bodey, GP; Karl, CL; Raad, II; Rolston, KV	1
Biron, P; Cure, H; Fuhrmann, C; Grès, JJ; Lefebvre, D; Rollin, C; Soler-Michel, P; Thyss, A; Viens, P; Viot, M	1
Aoun, M; Autier, P; Crokaert, F; Klastersky, J; Paesmans, M	1
Başkan, S; Ozyilkan, O; Yalçintaş, U	1
Kühl, J; Lehrnbecher, T; Stanescu, A	1
Dotti, M; Giacchino, M; Pavesio, D; Pecco, P	1
Craft, AW; Gray, JW; Kernahan, J; Pearson, AD; Pedler, S	1
Kuroe, K; Nakaji, S; Ogasawara, H; Saito, S; Sakata, Y; Sawada, Y; Shinagawa, H; Soma, N; Takami, H; Tsushima, K	1
Itoh, M; Nakano, T; Sakurai, M	1
Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV	1
Riikonen, P	1
Aizawa, T; Furuta, S; Ichikawa, S; Koike, Y; Maruyama, D; Nagata, A; Nishizawa, K; Saito, H; Yoda, H; Yoshizawa, S	1
Cristiano, P; Iovene, MR; Lobello, R; Pezza, M; Raucci, G; Simioli, F	1
Espinouse, D	1
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C	1
Cafiero, F; Caroti, C; Gipponi, M; Oliva, A	1
Inoue, M; Kawa, K; Konishi, S; Naya, Y; Nishida, M; Sako, M; Yabuuchi, H	1
Aihara, M; Chiba, Y; Haga, Y; Ogasawara, H; Sakata, Y; Sasaki, D; Sawada, Y; Suzuki, A; Takemori, H; Yoshida, Y	1
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ	1
Bodey, GP; Elting, L; Ho, DH	1
Alderman, HC; Alvarez, ME; Bodey, GP; Ho, DH; Hoy, JF; Rolston, KV	1
Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K	1
Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J	1
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV	1
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, P; Rolston, K; Steelhammer, L	1
Andremont, A; Baruchel, A; Hartmann, O; Tancrède, C	1
Bustamante, C; Devlin, A; Drusano, GL; Forrest, A; Plaisance, KI; Standiford, HC; Wade, JC	1
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L	1
Bustamante, CI; deJongh, C; Drusano, GL; Johnson, DE; Joshi, JH; Moody, MR; Schimpff, SC; Standiford, HC; Wade, JC	1

Reviews

1 review(s) available for imipenem, anhydrous and Neoplasms

Article	Year
Infectious complications in the immunocompromised host. The antimicrobial armamentarium. Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin	1993

Article

Year

Infectious complications in the immunocompromised host. The antimicrobial armamentarium.

Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4

Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin

1993

Trials

24 trial(s) available for imipenem, anhydrous and Neoplasms

Article	Year
Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2002, Volume: 15, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Cross-Over Studies; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Time Factors	2002
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer, 2003, Sep-01, Volume: 98, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin	2003
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome	2005
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatric hematology and oncology, 2007, Volume: 24, Issue:8 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate	2007
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1 Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin	1995
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido]. The Japanese journal of antibiotics, 1993, Volume: 46, Issue:5 Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis	1993
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer, 1996, Apr-01, Volume: 77, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin	1996
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin	1996
Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Prospective Studies; Thienamycins	1996
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients. Journal of experimental & clinical cancer research : CR, 1997, Volume: 16, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin	1997
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4 Topics: Antineoplastic Agents; Cefepime; Cephalosporins; Cilastatin; Drug Therapy, Combination; Fever; Humans; Imipenem; Neoplasms; Neutropenia; Risk Factors; Survival Analysis	1998
Imipenem versus targeted therapy in cancer patients. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoses; Neoplasms; Neutropenia; Thienamycins	1998
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. The Korean journal of internal medicine, 1999, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam	1999
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer. Infection, 2002, Volume: 30, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Imipenem; Infant; Infections; Injections, Intravenous; Male; Neoplasms; Neutropenia; Retrospective Studies; Teicoplanin; Time Factors	2002
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:8 Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Lincomycin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Pneumonia; Sepsis; Urinary Tract Infections	1992
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Archives of internal medicine, 1992, Volume: 152, Issue:2 Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection	1992
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. The Pediatric infectious disease journal, 1991, Volume: 10, Issue:12 Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin	1991
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicating hematological disorders and solid tumors]. The Japanese journal of antibiotics, 1991, Volume: 44, Issue:8 Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Myeloproliferative Disorders; Neoplasms	1991
Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases. Drugs under experimental and clinical research, 1990, Volume: 16, Issue:6 Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms	1990
[An imipenem-cilastatin combination in the treatment of infection in hemato-oncology]. Presse medicale (Paris, France : 1983), 1990, Apr-04, Volume: 19, Issue:13 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms	1990
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients. The American journal of medicine, 1988, Jul-25, Volume: 85, Issue:1A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins	1988
Imipenem/cilastatin therapy of infections in cancer patients. Cancer, 1987, Jul-15, Volume: 60, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins	1987
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. The American journal of medicine, 1988, Jul-25, Volume: 85, Issue:1A Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins	1988
Imipenem-cilastatin as initial therapy for febrile cancer patients. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:2 Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins	1986

Other Studies

31 other study(ies) available for imipenem, anhydrous and Neoplasms

Article	Year
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase. Bioorganic & medicinal chemistry letters, 2011, Aug-01, Volume: 21, Issue:15 Topics: Amidohydrolases; Animals; Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Metalloproteases; Mice; Mice, Nude; Neoplasms; Structure-Activity Relationship; Transplantation, Heterologous	2011
In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer. Journal of global antimicrobial resistance, 2022, Volume: 29 Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa	2022
Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine. BMC infectious diseases, 2022, Apr-18, Volume: 22, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Staphylococcus; Tertiary Care Centers	2022
Bacterial antibiotic resistance among cancer inpatients in China: 2016-20. QJM : monthly journal of the Association of Physicians, 2023, Mar-27, Volume: 116, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; China; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Inpatients; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus	2023
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia. International journal of antimicrobial agents, 2018, Volume: 51, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus	2018
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma. Turkish journal of medical sciences, 2015, Volume: 45, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors	2015
Imipenem in the treatment of febrile neutropenic children. Asian Pacific journal of cancer prevention : APJCP, 2009, Volume: 10, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Imipenem; Infant; Male; Medical Records; Neoplasm Staging; Neoplasms; Neutropenia; Retrospective Studies; Survival Rate; Treatment Outcome	2009
Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port. Journal of clinical microbiology, 2002, Volume: 40, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Catheterization, Central Venous; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Sequence Analysis, DNA; Thienamycins	2002
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Imipenem; Italy; Neoplasms; Retrospective Studies	2005
Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome	1989
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams. International journal of antimicrobial agents, 2006, Volume: 27, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies	2006
Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use. European journal of pediatrics, 1994, Volume: 153, Issue:2 Topics: Bacteremia; Child; Humans; Imipenem; Immunocompromised Host; Neoplasms	1994
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. The Pediatric infectious disease journal, 1993, Volume: 12, Issue:11 Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neutropenia	1993
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. International journal of clinical pharmacology research, 1996, Volume: 16, Issue:2-3 Topics: Adult; Bacteremia; Cancer Care Facilities; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Neoplasms; Pseudomonas Infections; Risk Factors; Shock, Septic; Slovakia; Thienamycins	1996
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratislavske lekarske listy, 1996, Volume: 97, Issue:11 Topics: Adult; Bacteremia; Drug Resistance, Microbial; Humans; Imipenem; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Thienamycins	1996
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Archives of internal medicine, 1998, Apr-27, Volume: 158, Issue:8 Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome	1998
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients? Cancer, 1998, Jun-15, Volume: 82, Issue:12 Topics: Adolescent; Adult; Aged; Cilastatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Protease Inhibitors; Retrospective Studies; Thienamycins; Treatment Outcome	1998
Imipenem use in serious childhood infections. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1 Topics: Antineoplastic Agents; Bacterial Infections; Child; Cystic Fibrosis; Humans; Imipenem; Neoplasms; Neutropenia; Retrospective Studies; Surgical Wound Infection; Thienamycins; Treatment Outcome	1991
Enterococcal superinfection in paediatric oncology patients treated with imipenem. Lancet (London, England), 1992, Jun-13, Volume: 339, Issue:8807 Topics: Bacteremia; Child; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Imipenem; Neoplasms; Superinfection	1992
[Clinical evaluation of imipenem/cilastatin sodium against infections in compromised children (malignancy, hematological disease, collagen disease)]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:8 Topics: Adolescent; Age Factors; Bacterial Infections; Child; Child, Preschool; Cilastatin; Collagen Diseases; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Infant; Male; Neoplasms; Neutropenia; Opportunistic Infections	1992
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia. Pediatric hematology and oncology, 1990, Volume: 7, Issue:3 Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin	1990
[Clinical evaluation of the tolerability of imipenem in the treatment of postoperative infections in oncologic surgery]. Minerva chirurgica, 1990, Volume: 45, Issue:1-2 Topics: Adult; Aged; Bacterial Infections; Drug Evaluation; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Postoperative Complications	1990
[Clinical study of imipenem/cilastatin sodium in children with severe infections]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1 Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Female; Hematologic Diseases; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia	1990
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Female; Hematologic Diseases; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutrophils	1989
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital. The American journal of medicine, 1988, Jul-25, Volume: 85, Issue:1A Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins	1988
In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Listeria monocytogenes; Neoplasms; Staphylococcus; Streptococcus; Thienamycins	1986
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:4 Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins	1986
Imipenem/cilastatin as secondary therapy for infections in cancer patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pneumonia; Sepsis; Thienamycins	1986
Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E Topics: Adolescent; Adult; Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Enterobacteriaceae; Female; Gram-Negative Bacteria; Humans; Imipenem; Intestines; Male; Neoplasms; Neutropenia; Thienamycins	1986
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:9 Topics: Adult; Aged; Agranulocytosis; Double-Blind Method; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Thienamycins	1987
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Agranulocytosis; Bacterial Infections; Drug Synergism; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Thienamycins	1985